In the liver, ERRα, primarily through its interaction with PGC-1α and activation of the AMPK/SIRT1 axis, enhances expression of genes involved in β-oxidation and oxidative phosphorylation, thereby preventing triglyceride accumulation and mitochondrial dysfunction typical of early MASLD. The gene discussed is ESRRA; the disease is metabolic dysfunction-associated steatotic liver disease.